Company intelligence / Profile preview

EBI Biotech

Seongnam-si, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

EBI Biotech is a South Korean biotechnology company specializing in the development of advanced stem cell therapies. The company focuses on isolating and cultivating high-purity mesenchymal stem cells to treat chronic and inflammatory diseases such as liver cirrhosis and atopic dermatitis. Their research and development efforts are centered on regenerative medicine and enhancing the therapeutic efficacy of cell-based treatments. EBI Biotech aims to provide innovative solutions for conditions with high unmet medical needs through its proprietary cell processing technologies.

Therapeutic areas: RheumatologyDermatologyGastroenterologyImmunology
Modalities: Cell therapyStem cell therapyBiologic
Industry: Biotech

Beyond the preview

Go deeper on EBI Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EBI Biotech.

Explore the full profile